185
Views
53
CrossRef citations to date
0
Altmetric
CaseReport

Rapid improvement of human orf (ecthyma contagiosum) with topical imiquimod cream: report of four complicated cases

, &
Pages 353-356 | Published online: 12 Jul 2009

References

  • Snyder R. R., Diven D. G. Orf (contagious pustular dermatitis, contagious ecthyma). Fitzpatrick's dermatology in general medicine, Vol. 2, 6th edn, I. M Freedberg, A. Z Eisen, K Wolff. McGraw‐Hill, New York 2003; 2110–13, In
  • Hawayek LH, Rubeiz N. Orf. www.emedicine.com/derm/topic605.htm
  • Braun‐Falco O., Plewig G. Viral diseases. Dermatology, 2nd edn, O Braun‐Falco, G Plewig, H. H Wolff. Springer‐Verlag, Berlin 2000; 82, In
  • Murphy J. K., Ralfs I. G. Bullous pemphigoid complicating human orf. Br J Dermatol 1996; 134: 929
  • Mourtada I., Le Tourneur M., Chevrant‐Breton J., Le Gall F. Human orf and erythema multiforme. Ann Dermatol Venereol 2000; 127: 397–9
  • Hunskaar S. Giant orf in a patient with chronic lymphocytic leukaemia. Br J Dermatol 1986; 114: 631–4
  • Tyring S., Conant M., Marini M. Imiquimod; an international update on therapeutic uses in dermatology. Int J Dermatol 2002; 41: 810–16
  • Berman B., Hengge U., Barton S. Successful management of viral infections and other dermatoses with imiquimod 5% cream. Acta Derm Venereol Suppl 2003; 12–17
  • Hengge U. R., Cusini M. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum. Br J Dermatol 2003; 149((Suppl 66))15–19
  • Kuhl J. T., Huerter C. J., Hashish H. A case of human orf contracted from a deer. Cutis 2003; 71: 288–90
  • Haig D. M., McInnes C. J. Immunity and counter‐immunity during infection with the parapoxvirus orf virus. Virus Res 2002; 88: 3–16
  • Bacakoglu A. K., Ozkan M., Ekin A. Stay away from surgery: ecthyma contagiosum. Handchir Mikrochir Plast Chir 2001; 33: 283–6
  • Freeman G., Bron A. J., Juel‐Jensen B. Ocular infection with orf virus. Am J Ophthalmol 1984; 97: 601–4
  • Bodnar M. G., Miller O. F 3rd., Tyler W. B. Facial orf. J Am Acad Dermatol 1999; 40: 815–17
  • Geerinck K., Lukito G., Snoeck R., De Vos R., De Clercq E., Vanrenterghem Y., et al. A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol 2001; 64: 543–9
  • Ocampo Candiani J., Gonzalez Soto R., Welsh Lozano O. Orf nodule: treatment with cryosurgery. J Am Acad Dermatol 1993; 29: 256–7
  • Tan S. T., Blake G. B., Chambers S. Recurrent orf in an immunocompromised host. Br J Plast Surg 1991; 44: 465–7
  • Savage J., Black M. M. ‘Giant’ orf of finger in a patient with a lymphoma. Proc R Soc Med 1972; 65: 766–8
  • Micali G., De Pasquale R., Caltabiano R., Impallomeni R., Lacarrubba F. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatol Treat 2002; 13: 123–7
  • Suchin K. R., Junkins‐Hopkins J. M., Rook A. H. Treatment of stage IA cutaneous T‐cell lymphoma with topical application of the immune response modifier imiquimod. Arch Dermatol 2002; 138: 1137–9
  • Martinez M. I., Sanchez‐Carpintero I., North P. E. Infantile hemangioma clinical resolution with 5% imiquimod cream. Arch Dermatol 2002; 138: 881–4
  • Sauder D. N. Imiquimod: modes of action. Br J Dermatol 2003; 149((Suppl 66))5–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.